Maithreye Rengaswamy

Principal Scientist
Vantage Research, India

Poster(s):

• (S-017) Optimal therapeutic combinations for Phase 3 UC trial design- recommendations from a QSP platform model
  Sunday, October 19, 2025

  7:00 AM - 5:00 PM MDT